The “Göteborg-2 trial”; A prospective, randomized, population-based trial of prostate cancer screening with PSA testing followed by MRI of the prostate.
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.